Answers are grounded in this paper and cite their sources.
We would like to update the data contained in our recent article1 and provide some new information. After we submitted our article, Bausch & Lomb Surgical provided research funding for our small microkeratome blade study. Prior to publication, we presented our findings of debris on the surface of sterile, unused Chiron (ACS microkeratome) blades to Bausch & Lomb Surgical. Additionally, we presented information that we did not publish, obtained by using high-pressure liquid chromatography to analyze the acetone that we used to clean the sterile microkeratome blades. This study revealed that the contaminant was a wax or oil. Funding restrictions prohibited further research to precisely identify the material(s). At no time did Bausch & Lomb Surgical discourage us from publishing our findings. The second phase of our study, designed to identify the contaminant(s) and devise an effective cleaning technique for the microkeratome blades, was not funded and has progressed on a limited level. However, it is our understanding that Bausch & Lomb Surgical has instituted a new multistep cleaning technique for their microkeratome blades as part of the blade manufacturing process. In a small study of 3 of the newer blades, we found that 90% of the interface debris was eliminated compared with the original “uncleaned” blades tested. Moreover, none of the 3 corneal flap interfaces produced using these new blades revealed inflammatory cells at 24 hours. These findings suggest that the new cleaning process may have eliminated the contaminant that we discovered in our published study. Of course, this was a small study that cannot claim to present a definitive answer regarding the elimination of debris on the microkeratome blades. While we await a definitive study to settle this question and the ultimate question of the cause of the interface keratitis that occurs after laser in situ keratomileusis (LASIK) (Sands of the Sahara syndrome), we would like to emphasize the following: (1) Bausch & Lomb Surgical is to be commended for taking quick action to address this problem. (2) We will continue to clean our blades, as described in our article, until a larger study can be performed. (Incidentally, we have had no documented cases of post-LASIK interface keratitis since we instituted our blade cleaning regimen.) (3) We have observed significant post-LASIK interface debris when using microkeratomes from 2 other manufacturers. Thus, it may be beneficial to clean the microkeratome blades from other manufacturers. Stephen C. Kaufman MD, PhD New Orleans, Louisiana, USA
No takes yet. Share an insight, caveat, or question.
Stephen C. Kaufman (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: